Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
Anaël AyrollesPierre EllulVincent TrebossenNadira Houhou-FidouhStephane BonacorsiDiane DescampsRichard DelormePublished in: Neuropsychopharmacology reports (2022)
This suggests a lower direct impact of SARS-CoV-2 compared with the impact of mitigation strategies on psychiatric symptom deterioration in children reported since early stages of the pandemic.